Nausea, Liver enzyme increased, Conjunctivitis, Dehydration, Diarrhoea, Intestinal injury, Headache, Decreased calcium level in blood, Decreased magnesium level in blood, Weakness, Infusion site reaction, Loss of appetite, Nasal mucous injury, Skin reaction, Vomiting
Frequently Ask Questions:
Q. Is cetuximab a chemotherapy drug?
Cetuximab is a cytotoxic drug that is used in the chemotherapy of cancers of colon and rectum, and head-neck cancers
Q. Is cetuximab cytotoxic agent or vesicant or radiosensitizer?
It is not a radiosensitizer, but usually used in combination with radiotherapy to treat the cancers. It is not a vesicant (irritant)
Q. Is cetuximab US FDA approved?
Yes, cetuximab is approved by US FDA in 2009 to treat certain type of cancer of colon, rectum and head-neck cancer
Q. How is cetuximab administered?
Cetuximab is generally administered by intravenous (IV infusion) route, with or without radiotherapy
Q. Does cetuximab cause hair loss?
Yes. Cetuximab is a chemotherapy agent, which may cause hair loss. Please consult your doctor if you experience such side effect
Q. Why does cetuximab cause a rash?
Cetuximab may cause rashes
Q. How long does the rash last?
The duration of skin rash depends upon its type and severity. Please consult your doctor for advice.